topotecan has been researched along with sb 218078 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilmartin, A; Imburgia, C; Jackson, JR; Marshall, LA; Roshak, A; Winkler, JD | 1 |
1 other study(ies) available for topotecan and sb 218078
| Article | Year |
|---|---|
An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
Topics: Alkaloids; Cell Cycle; Checkpoint Kinase 1; DNA Damage; Enzyme Inhibitors; G2 Phase; Humans; Protein Kinase Inhibitors; Protein Kinases; Schizosaccharomyces pombe Proteins; Topoisomerase I Inhibitors; Topotecan | 2000 |